Charles Schwab Investment Management Inc Compass Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 297,880 shares of CMPX stock, worth $947,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
297,880
Previous 286,191
4.08%
Holding current value
$947,258
Previous $414,000
36.47%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CMPX
# of Institutions
121Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$71.1 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$35.1 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$31.9 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$26.8 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$21 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $322M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...